The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tellier, M. C.
Right arrow Articles by Schnapp, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tellier, M. C.
Right arrow Articles by Schnapp, L. M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2000, 164: 3236-3245.
Copyright © 2000 by The American Association of Immunologists

Superfibronectin, a Multimeric Form of Fibronectin, Increases HIV Infection of Primary CD4+ T Lymphocytes1

Marinka C. Tellier2,*, Giampaolo Greco2,*, Mary Klotman{dagger}, Arevik Mosoian{dagger}, Andrea Cara{dagger}, Wadih Arap3,{ddagger}, Erkki Ruoslahti{ddagger}, Renata Pasqualini3,{ddagger} and Lynn M. Schnapp4,*

Divisions of * Pulmonary and Critical Care Medicine and {dagger} Infectious Disease, Mount Sinai School of Medicine, New York, NY 10029; and {ddagger} Cancer Research Center, The Burnham Institute, La Jolla, CA 92037.

The ability of viruses and bacteria to interact with the extracellular matrix plays an important role in their infectivity and pathogenicity. Fibronectin is a major component of the extracellular matrix in lymph node tissue, the main site of HIV deposition and replication during the chronic phase of infection. Therefore, we asked whether matrix fibronectin (FN) could affect the ability of HIV to infect lymphocytes. To study the role of matrix FN on HIV infection, we used superfibronectin (sFN), a multimeric form of FN that closely resembles in vivo matrix FN. In this study we show that HIV-1IIIB efficiently binds to multimeric fibronectin (sFN) and that HIV infection of primary CD4+ lymphocytes is enhanced by >1 order of magnitude in the presence of sFN. This increase appears to be due to increased adhesion of viral particles to the cell surface in the presence of sFN, followed by internalization of virus. Enzymatic removal of cell surface proteoglycans inhibited the adhesion of HIV-1IIIB/sFN complexes to lymphocytes. In contrast, Abs to integrins had no effect on binding of HIV-1IIIB/sFN complexes to lymphocytes. The III1-C peptide alone also bound HIV-1IIIB efficiently and enhanced HIV infection, although not as effectively as sFN. HIV-1IIIB gp120 envelope protein binds to the III1-C region of sFN and may be important in the interaction of virus with matrix FN. We conclude that HIV-1IIIB specifically interacts with the III1-C region within matrix FN, and that this interaction may play a role in facilitating HIV infection in vivo, particularly in lymph node tissue.




This article has been cited by other articles:


Home page
J. Bacteriol.Home page
C. E. Cameron, E. L. Brown, J. M. Y. Kuroiwa, L. M. Schnapp, and N. L. Brouwer
Treponema pallidum Fibronectin-Binding Proteins
J. Bacteriol., October 15, 2004; 186(20): 7019 - 7022.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. H. Birdsall, W. J. Porter, D. M. Green, J. Rubio, J. Trial, and R. D. Rossen
Impact of Fibronectin Fragments on the Transendothelial Migration of HIV-Infected Leukocytes and the Development of Subendothelial Foci of Infectious Leukocytes
J. Immunol., August 15, 2004; 173(4): 2746 - 2754.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Trial, J. A. Rubio, H. H. Birdsall, M. Rodriguez-Barradas, and R. D. Rossen
Monocyte Activation by Circulating Fibronectin Fragments in HIV-1-Infected Patients
J. Immunol., August 1, 2004; 173(3): 2190 - 2198.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. M. Brainard, W. G. Tharp, E. Granado, N. Miller, A. K. Trocha, X.-H. Ren, B. Conrad, E. F. Terwilliger, R. Wyatt, B. D. Walker, et al.
Migration of Antigen-Specific T Cells Away from CXCR4-Binding Human Immunodeficiency Virus Type 1 gp120
J. Virol., May 15, 2004; 78(10): 5184 - 5193.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Pal and L. M. Schnapp
HIV-Infected Lymphocytes Regulate Fibronectin Synthesis by TGF{beta}1 Secretion
J. Immunol., March 1, 2004; 172(5): 3189 - 3195.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. C. Hocking and C. H. Chang
Fibronectin matrix polymerization regulates small airway epithelial cell migration
Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L169 - L179.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. Sottile and D. C. Hocking
Fibronectin Polymerization Regulates the Composition and Stability of Extracellular Matrix Fibrils and Cell-Matrix Adhesions
Mol. Biol. Cell, October 1, 2002; 13(10): 3546 - 3559.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Lei, B. Bajaj, and S. T. Andreadis
Retrovirus-Associated Heparan Sulfate Mediates Immobilization and Gene Transfer on Recombinant Fibronectin
J. Virol., July 29, 2002; 76(17): 8722 - 8728.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
D. C. Hocking and K. Kowalski
A cryptic fragment from fibronectin's III1 module localizes to lipid rafts and stimulates cell growth and contractility
J. Cell Biol., July 8, 2002; 158(1): 175 - 184.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Greco, S. Pal, R. Pasqualini, and L. M. Schnapp
Matrix Fibronectin Increases HIV Stability and Infectivity
J. Immunol., June 1, 2002; 168(11): 5722 - 5729.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
X. Liu and P. Collodi
Novel Form of Fibronectin from Zebrafish Mediates Infectious Hematopoietic Necrosis Virus Infection
J. Virol., January 15, 2002; 76(2): 492 - 498.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.